Myrexis, Inc.
MYRX
$0.007
$0.000.00%
OTC PK
| 06/30/2013 | 03/31/2013 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -13,250.00% | -- | |||
| Gross Profit | 13,250.00% | -- | |||
| SG&A Expenses | -93.42% | -49.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -93.71% | -49.87% | |||
| Operating Income | 93.71% | 49.87% | |||
| Income Before Tax | 95.34% | 32.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 95.34% | 32.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 95.34% | 32.66% | |||
| EBIT | 93.71% | 49.87% | |||
| EBITDA | 93.69% | 48.38% | |||
| EPS Basic | 95.94% | 39.40% | |||
| Normalized Basic EPS | 94.48% | 54.69% | |||
| EPS Diluted | 95.94% | 39.40% | |||
| Normalized Diluted EPS | 94.48% | 54.69% | |||
| Average Basic Shares Outstanding | 15.27% | 11.06% | |||
| Average Diluted Shares Outstanding | 15.27% | 11.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||